Legal Implications of iRhythm’s Challenge to Patent Assertion Timelines Unfold at USPTO
A legal debate is unfolding involving a heart monitoring company, iRhythm, which has raised an argument before the acting U.S. Patent and Trademark Office (USPTO) director. The company contends that it should not be excluded from contesting a patent simply because it has been aware of the patent’s existence for 12 years, especially since the…